Page 156 - book

CinnaGen Co.

Dosage
Type Product Strength Indication Status
Form
Prostate Cancer,
CinnaFact® (Buserelin
Drug Vial 1 mg/ ml Endometriosis, In Production
Acetate)
Ovulation induction
250 mcg/ IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
Drug CinnoPar® (Teriparatide) Pen Osteoporosis In Production
ml,2.4ml
PFS/ Auto-
PegaGen® (Pegfilgrastim) injector 6 mg/0.6 ml
Drug Post-chemotherapy In Production
Neutropenia
KidiPeg® (Pegfilgrastim) PFS/ Auto- 3 mg/0.3 ml
injector
PFS/ Auto-
Drug CinnoRA® (Adalimumab) 40 mg/0.8 ml Rheumatoid Arthritis In Production
injector
Diabetes mellitus, Chronic Weight Man-
Drug Melitide® (Liraglutide) Pen 18 mg/3 ml In Production
agement
Drug Pectuna® Vial 420 mg/14 ml HER2-positive metastatic breast cancer In Production
Paroxysmal nocturnal hemoglobinuria
Drug Ablyze® Vial 300 mg/30 ml (PNH), Atypical hemolytic uremic syn- In Production
drome (aHUS)
Drug Xacrel® Vial 300 mg/10 ml Multiple sclerosis In Production
Melanoma, Non-small cell lung cancer,
Hodgkin lymphoma,
Drug Zak Aria® Vial 100 mg/4 ml In Production
Urothelial carcinoma,Head and neck
squamous cell cancer
100 mg/10 ml
Drug Xtramab® Vial 40 mg/4 ml Non-Small Cell Lung Cancer (NSCLC) In Production
240 mg/24 ml
Moderate to severe persistent asthma,
Drug Zerafil® PFS 150mg/ ml In Production
Chronic idiopathic urticaria
Single dose
Drug SpikoGen® Vial Prevent COVID-19 In Production
16 dose
2000 IU
4000 IU
Drug CinnaStim® PFS 6000 IU deep vein thrombosis (DVT) In Production
8000 IU
10000 IU
Drug Gylava® PEN 100 Units/ml Type 1 & 2 diabetes mellitus In Production
Neovascular (Wet) Age-Related Macular
Degeneration (AMD) , Macular Edema
Drug Tyalia® Vial 4 mg/0.1 ml Following Retinal Vein Occlusion (RVO) , In Production
Diabetic Macular Edema , Diabetic Reti-
nopathy (DR) in Patients with DME

Drug Kidimab® PFS 20 mg/0.4 ml Rheumatoid Arthritis In Production
Diabetes mellitus, Chronic Weight Man-
Drug Maciza® Pen 18 mg/3 ml In Production
agement
Pen 5 mg/1.5 ml
Drug CinnaTropin® (Somatropin) Pen 10 mg/1.5 ml Growth Hormone deficiency In Production
Vial 4 IU 155